RESUMEN
BACKGROUND: Loss or mutations of the BRCA1 gene are associated with increased risk of breast and ovarian cancers and with prostate cancer (PCa) aggressiveness. Previously, we identified GADD153 as a target of BRCA1 protein, which increases doxorubicin sensitivity in human p53 -/- PCa cells (PC3). Considering that p53 is a crucial target in cancer therapy, in this work we investigated p53 role in the regulation of transcription of GADD153. METHODS: We performed reverse transcription quantitative PCR (RT-qPCR), western blot and luciferase assays to analyze GADD153 and/or BRCA1 expression in response to ultraviolet or doxorubicin exposure in PC3 p53 stable-transfected cells and LNCaP (p53+/+) cells. BRCA1 protein recruitment to GADD153 promoter was studied by chromatin immunoprecipitation-qPCR. To assess expression of BRCA1 and/or p53 target genes, we used a panel of stable-transfected PCa cell lines. We finally analyzed these genes in vivo using BRCA1-depleted PCa xenograft models. RESULTS: We found that GADD153 was highly induced by doxorubicin in PC3 cells; however, this response was totally abolished in LNCaP (p53wt) and in p53-restituted PC3 cells. Furthermore, BRCA1 protein associates to GADD153 promoter after DNA damage in the presence of p53. Additionally, we demonstrated that BRCA1 and/or p53 modulate genes involved in DNA damage and cell cycle regulation (cyclin D1, BLM, BRCA2, DDB2, p21(WAF1/CIP1), H3F3B, GADD153, GADD45A, FEN1, CCNB2), EMT (E-cadherin, ß-catenin, vimentin, fibronectin, slug, snail) and Hedgehog pathways (SHH, IHH, DHH, Gli1, PATCH1). Furthermore, xenograft studies demonstrated that BRCA1 knockdown in PC3 cells increased tumor growth and modulated these genes in vivo. CONCLUSIONS: Although BRCA1 induces GADD153 in a p53 independent manner, p53 abolished GADD153 induction in response to DNA damage. In addition, several important PCa targets are modulated by BRCA1 and p53. Altogether, these data might be important to understand the therapy response of PCa patients.
Asunto(s)
Proteína BRCA1/metabolismo , Neoplasias de la Próstata/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Animales , Proteína BRCA1/genética , Ciclo Celular/genética , Línea Celular Tumoral , Daño del ADN , Erizos/genética , Erizos/metabolismo , Xenoinjertos , Humanos , Masculino , Ratones , Neoplasias de la Próstata/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transducción de Señal , Factor de Transcripción CHOP/metabolismo , Transcripción Genética , Proteína p53 Supresora de Tumor/genéticaRESUMEN
The tendency of prostate cancer to produce osteoblastic bone metastases suggests that cancer cells and osteoblasts interact in ways that contribute to cancer progression. To identify factors that mediate these interactions, we compared gene expression patterns between two bone-derived prostate cancer cell lines that produce osteoblastic (MDA PCa 2b) or osteolytic lesions (PC-3). Both cell lines expressed Wnt ligands, including WNT7b, a canonical Wnt implicated in osteogenesis. PC-3 cells expressed 50 times more Dickkopf-1 (DKK1), an inhibitor of Wnt pathways, than did MDA PCa 2b cells. Evaluation of the functional role of these factors (in cocultures of prostate cancer cells with primary mouse osteoblasts (PMOs) or in bone organ cultures) showed that MDA PCa 2b cells activated Wnt canonical signaling in PMOs and that DKK1 blocked osteoblast proliferation and new bone formation induced by MDA PCa 2b cells. MDA PCa 2b cells did not induce bone formation in calvaria from mice lacking the Wnt co-receptor Lrp5. In human specimens, WNT7b was not expressed in normal prostate but was expressed in areas of high-grade prostate intraepithelial neoplasia, in three of nine primary prostate tumor specimens and in 16 of 38 samples of bone metastases from prostate cancer. DKK1 was not expressed in normal or cancerous tissue but was expressed in two of three specimens of osteolytic bone metastases (P=0.0119). We conclude that MDA PCa 2b induces new bone formation through Wnt canonical signaling, that LRP5 mediates this effect, and that DKK1 is involved in the balance between bone formation and resorption that determines lesion phenotype.
Asunto(s)
Neoplasias Óseas/secundario , Proteínas Relacionadas con Receptor de LDL/metabolismo , Neoplasias de la Próstata/metabolismo , Proteínas Wnt/metabolismo , Animales , Neoplasias Óseas/metabolismo , Línea Celular Tumoral , Humanos , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Proteína-5 Relacionada con Receptor de Lipoproteína de Baja Densidad , Masculino , Ratones , Osteoblastos/metabolismo , Osteólisis , Fenotipo , Neoplasias de la Próstata/patología , Transducción de SeñalRESUMEN
1. The effect of in vitro glycation on delta-aminolevulinic dehydratase (ALA-D) under several experimental conditions was investigated. When preincubated with 500 mM glucose at 37 degrees C for 20 hr, ALA-D was 80% inactivated and glycated hemoglobin levels were increased more than fourfold. 2. Thiobarbituric acid species were not modified during glycation; therefore ALA-D inactivation cannot be attributed to glucose autoxidation. 3. Acetyl salicylic acid was effective in preventing both hemoglobin glycation and ALA-D inactivation by glucose. 4. A method has been developed for measuring protein glycation in vitro, in a crude preparation of red blood cells, which can also be applied to sugars other than glucose.
Asunto(s)
Aspirina/farmacología , Glucosa/metabolismo , Porfobilinógeno Sintasa/metabolismo , Metabolismo de los Hidratos de Carbono , Carbohidratos/farmacología , Glucosa/farmacología , Hemoglobina Glucada/metabolismo , Glicosilación/efectos de los fármacos , Humanos , Técnicas In Vitro , Peroxidación de Lípido/efectos de los fármacos , Porfobilinógeno Sintasa/antagonistas & inhibidores , Temperatura , Factores de TiempoRESUMEN
1. The effect of long-term griseofulvin (GRIS) topical administration on some indicators of liver damage was examined. 2. Liver porphyrin accumulation was significant; however, no porhyrin crystals were observed under light microscopy. 3. An earlier onset of hepatopathy was established (3-fold) increase of direct bilirubin values after 7 days of treatment; hepatic injury was confirmed by measuring a 6-fold increase of free bilirubin. 4. Enhanced values of alkaline phosphatase and glutamic oxalacetic transaminase (GOT) confirmed the onset of cholestasis. 5. Topical application of GRIS induced measurable hepatopathy. Nevertheless, we cannot discard the possibility that this hepatopathy could also be attributed in part to a direct reaction to xenobiotics.
Asunto(s)
Antifúngicos/farmacología , Griseofulvina/farmacología , Hemo/metabolismo , Hígado/efectos de los fármacos , Administración Tópica , Animales , Antifúngicos/administración & dosificación , Biomarcadores , Griseofulvina/administración & dosificación , Hígado/enzimología , Hígado/patología , Pruebas de Función Hepática , Masculino , RatonesRESUMEN
1. The effect of chronic enflurane or isoflurane anesthesia on hepatic heme regulation and the drug-metabolizing system in mice treated or not with phenobarbital (PB) was investigated. 2. delta-Aminolevulinic acid synthetase was induced 50-170% in all cases. Urinary porphyrin precursor excretion was also enhanced, but these values were lower when animals also received PB. 3. Cytochrome (CYT) P-450 levels were enhanced in animals treated with enflurane whether or not they were given PB. 4. Gluthatione-S-transferase activity was induced by enflurane (138%) or isoflurane (174%), and even more in animals receiving PB also. Sulfatase activity was increased more than 60% with anesthetics. Isoflurane produced a 50% increase of beta-glucuronidase activity and a 35% diminution of tryptophan pyrrolase. 5. The association between anesthetics and PB produced diverse effects on the metabolizing enzyme system. 6. Data suggest that both anesthetics, chemically related, could act through two different mechanisms, however, with the same final effect: heme pathway deregulation.
Asunto(s)
5-Aminolevulinato Sintetasa/metabolismo , Anestésicos por Inhalación/farmacología , Sistema Enzimático del Citocromo P-450/metabolismo , Enflurano/farmacología , Hemo/metabolismo , Hipnóticos y Sedantes/farmacología , Isoflurano/farmacología , Hígado/efectos de los fármacos , Fenobarbital/farmacología , Ácido Aminolevulínico/orina , Animales , Hígado/enzimología , Masculino , Ratones , Porfobilinógeno/orina , Porfirinas/metabolismoRESUMEN
1. The effect of enflurane or isoflurane anesthesia (1 ml/kg, i.p.) in animals chronically treated with ethanol (30%, v/v, in drinking water during a week) on heme metabolism and its regulation was investigated. 2. In those animals previously intoxicated with ethanol that received isoflurane, ALA-S activity was increased (control values: 0.071 +/- 0.022 nmol/mg, n = 10; treated animals: 0.110 +/- 0.034 nmol/mg, n = 8) and blood PBGase and deaminase were strikingly diminished (control values, n = 10: PBGase: 0.101 +/- 0.015 nmol/mg, deaminase: 0.242 +/- 0.075 nmol/mg; treated animals, n = 6: PBGase: 0.063 +/- 0.013 nmol/mg; deaminase: 0.145 +/- 0.045 nmol/mg). 3. The time-response study showed that liver ALA-S is enhanced at shorter times of anesthesia with isoflurane and that blood PBGase and deaminase appeared inhibited later in animals previously treated with ethanol. 4. Results reproduce some biochemical alterations known to occur in acute intermittent porphyria.
Asunto(s)
Etanol/farmacología , Éteres/farmacología , Hemo/metabolismo , Animales , Enflurano/farmacología , Hígado/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos , Factores de TiempoRESUMEN
A frequent coexistence of diabetes and porphyria disease has been reported. Under normal conditions, porphyrin biosynthesis is well regulated to only form the amount of heme required for the synthesis of the various hemoproteins. The activity of some heme enzymes and rhodanese in streptozotocin (STZ) induced diabetic mice and in allylisopropylacetamide (AIA) induced experimental acute porphyria mice has been examined. The role of alpha-tocopherol (alpha-T), reported to prevent protein glycation in vitro, has also been investigated. AIA induced hepatic delta-aminolevulinic acid synthetase (ALA-S) activity in control animals but was ineffective in the diabetic group. alpha-Tocopherol did not modify ALA-S activity in either group. delta-Aminolevulinic acid dehydratase (ALA-D) and deaminase activities were significantly diminished both in liver and blood of diabetic animals. alpha-Tocopherol prevented inhibition of ALA-D, deaminase and blood rhodanese activities in diabetic animals but alpha-tocopherol by itself did not affect the basal levels of the enzymes studied. The potential use of alpha-tocopherol to prevent late complications of diabetes, including the onset of a porphyria like syndrome is considered.
Asunto(s)
Alilisopropilacetamida/toxicidad , Diabetes Mellitus Experimental/enzimología , Porfiria Intermitente Aguda/enzimología , Vitamina E/farmacología , 5-Aminolevulinato Sintetasa/sangre , 5-Aminolevulinato Sintetasa/metabolismo , Animales , Glucemia/análisis , Glucemia/efectos de los fármacos , Hemo/metabolismo , Masculino , Ratones , Nucleósido Desaminasas/sangre , Nucleósido Desaminasas/metabolismo , Porfobilinógeno Sintasa/sangre , Porfobilinógeno Sintasa/metabolismo , Porfiria Intermitente Aguda/inducido químicamente , Estreptozocina/toxicidad , Tiosulfato Azufretransferasa/metabolismoRESUMEN
1. Heme regulation before the appearance of hyperplastic nodules was investigated in mice models of hepatocarcinogenesis. 2. With this aim 5-aminolaevulinate synthetase (ALA-S), microsomal heme-oxygenase (MHO), mitochondrial and cytoplasmic rhodanese activities were examined throughout a period of 35 days in animals exposed to dietary p-dimethylaminoazobenzene (DAB). 3. ALA-S activity was significantly diminished (50%) on day 14, then showing a sharply rising profile from day 28 onwards, and reaching 350% on day 35. 4. A similar profile was observed for mitochondrial rhodanese activity. 5. Changes in MHO and cytoplasmic rhodanese activities were almost the opposite to those observed for ALA-S. 6. The distinctive alteration in mitochondrial and cytoplasmic rhodanese would suggest that it plays a subtle role in ALA-S regulation during carcinogenesis initiation through a mechanism that appears to involve subcellular localization controls perhaps by means of the breakage of cystine trisulphide postulated to act as an ALA-S activator. 7. Taking into account the present results, we suggest a probable mechanism for the onset of hepatocarcinogenesis that includes a primary activating liver status, provoking biochemical aberration leading to the stage of initiation of hepatocarcinogenesis involving the whole organ.
Asunto(s)
Hemo/biosíntesis , Neoplasias Hepáticas Experimentales/metabolismo , 5-Aminolevulinato Sintetasa/metabolismo , Animales , Citoplasma/enzimología , Hemo Oxigenasa (Desciclizante)/metabolismo , Cinética , Hígado/enzimología , Neoplasias Hepáticas Experimentales/inducido químicamente , Masculino , Ratones , Microsomas Hepáticos/enzimología , Mitocondrias Hepáticas/enzimología , Tiosulfato Azufretransferasa/metabolismo , p-DimetilaminoazobencenoRESUMEN
1. Basal levels and allyl-isopropylacetamide (AIA) or veronal induced levels of delta-amino-levulinate synthetase (ALA-S), cytoplasmic and mitochondrial rhodanese were determined in tumor (T) and liver of both normal mice (NM) and T-bearing mice (TBM). 2. Rhodanese tumoral mitochondrial levels were higher than the hepatic normal mitochondrial fraction, while the cytoplasmic activity was nearly equal in all sources. 3. In neither case was the activity of tumoral ALA-S and rhodanese altered by any of the porphyrinogenic drugs. 4. Mitochondrial and cytoplasmic rhodanese activity was also measured in tumor and liver of TBM at different intervals after transplantation. We concluded that the behaviour of rhodanese is a property inherent to the tissue and not one attained with time.
Asunto(s)
5-Aminolevulinato Sintetasa/metabolismo , Neoplasias Mamarias Experimentales/enzimología , Tiosulfato Azufretransferasa/metabolismo , 5-Aminolevulinato Sintetasa/biosíntesis , Alilisopropilacetamida/farmacología , Animales , Barbital/farmacología , Citoplasma/enzimología , Inducción Enzimática/efectos de los fármacos , Hígado/enzimología , Masculino , Ratones , Ratones Endogámicos BALB C , Mitocondrias/enzimología , Tiosulfato Azufretransferasa/biosíntesisRESUMEN
1. delta-Aminolevulinic acid synthetase (ALA-S), rhodanese and microsomal heme oxygenase (MHO), were quantitated in Cl4C induced regenerating mouse liver. 2. Maximal hepatomegalia was observed at 48 hr after i.p. injection of a single dose of the toxin. 3. ALA-S activity decreased on day 2, and then significantly increased (50%) between days 3 and 7, returning afterwards to control values. 4. Cytoplasmic rhodanese, as well as MHO activities, exhibited a clear correlation as compared with the ALA-S activity profile. 5. Porphyrin biosynthesis from precursor delta-aminolevulinic acid (ALA) was significantly increased even after 15 days of intoxication. 6. Present results would indicate that Cl4C is acting in a dual fashion.
Asunto(s)
Hemo/metabolismo , Regeneración Hepática/fisiología , Hígado/metabolismo , 5-Aminolevulinato Sintetasa/metabolismo , Ácido Aminolevulínico/metabolismo , Animales , Tetracloruro de Carbono/farmacología , Sistema Enzimático del Citocromo P-450/deficiencia , Hemo Oxigenasa (Desciclizante)/metabolismo , Cinética , Hígado/efectos de los fármacos , Hígado/enzimología , Regeneración Hepática/efectos de los fármacos , Ratones , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Porfirinas/biosíntesis , Tiosulfato Azufretransferasa/metabolismoRESUMEN
1. A clear biphasic response of the enzyme activities as a function of intoxication time due to the topical cutaneous griseofulvin treatment was observed. 2. The initial acute induction of ALA-S activity would be due to depletion of free heme in the regulatory pool caused by cytochrome P 450 destruction. 3. The second induction peak, would be due to less heme formation, secondary to the ferrochelatase inhibition, as expected for the erythropoietic protoporphyria model. 4. The biphasic response of hepatic ALA-D and PBGase activities would be related to ALA-S activity changes and the subsequent augmented available substrates. 5. Endogenous liver porphyrin distribution in cytosolic, mitochondrial and nuclear fractions was investigated. 6. The in vitro biosynthesis of porphyrins confirmed both the biphasic model and the hepatic porphyrins subcellular distribution. 7. Two mechanisms to explain the action of griseofulvin at shorter and longer times of intoxication are proposed.
Asunto(s)
Griseofulvina/farmacología , Hemo/metabolismo , 5-Aminolevulinato Sintetasa/metabolismo , Amoníaco-Liasas/metabolismo , Animales , Núcleo Celular/efectos de los fármacos , Núcleo Celular/enzimología , Sistema Enzimático del Citocromo P-450/metabolismo , Citosol/efectos de los fármacos , Citosol/enzimología , Técnicas In Vitro , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Masculino , Ratones , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/enzimología , Porfobilinógeno Sintasa/metabolismo , Porfirinas/metabolismo , Proteínas/metabolismoRESUMEN
1. Some in vitro studies were performed to elucidate the action of S-adenosyl-L-methionine (SAM) and thiosulphate on liver rhodanese, delta-amino-levulinic acid dehydratase (Al A-D) and cytochrome oxidase affected by cyanide in the experimental conditions. 2. SAM was unable to interact with the sulfur substituted rhodanese complex suggesting that SAM would blockade the thiosulphate binding sites on rhodanese. 3. Cyanide and thiosulphate inhibited ALA-D activity when both compounds were present in the incubation or the preincubation mixture. Cyanide binding on the enzyme was irreversible. 4. Cyanide inhibited cytochrome oxidase activity and the reversible nature of the binding was demonstrated by gel filtration. 5. SAM had no effect on either ALA-D or cytochrome oxidase activities.
Asunto(s)
Cianuros/farmacología , S-Adenosilmetionina/farmacología , Tiosulfato Azufretransferasa/antagonistas & inhibidores , Tiosulfatos/farmacología , Animales , Complejo IV de Transporte de Electrones/metabolismo , Técnicas In Vitro , Hígado/efectos de los fármacos , Hígado/enzimología , Ratones , Porfobilinógeno Sintasa/metabolismoRESUMEN
1. The effect of acute cyanide administration to mice in a lethal and a non-lethal dose and the anti-cyanide effect of S-adenosyl-L-methionine (SAM) and thiosulphate were investigated. 2. The poisoning action was determined by measuring cytochrome oxidase, rhodanese and delta-aminolevulinic acid dehydratase (ALA-D) activity. 3. The toxic metabolizing degree was investigated by measuring plasma and urine thiocyanate levels. 4. The state of the sulfane sulfur pool was investigated by determining cyanide labile-sulfur levels. 5. These results support the belief that rhodanese plays a fundamental role in the detoxification process only when high levels of cyanide are administered.
Asunto(s)
Cianuros/toxicidad , Animales , Cianuros/administración & dosificación , Cianuros/sangre , Complejo IV de Transporte de Electrones/antagonistas & inhibidores , Dosificación Letal Mediana , Ratones , Porfobilinógeno Sintasa/metabolismo , Proteínas/metabolismo , S-Adenosilmetionina/farmacología , Radioisótopos de Azufre , Tiocianatos/sangre , Tiocianatos/orina , Tiosulfato Azufretransferasa/antagonistas & inhibidores , Tiosulfatos/sangre , Tiosulfatos/farmacologíaRESUMEN
1. Several sub-lethal doses of cyanide were assayed with the aim of obtaining significant differences in the parameters studied. A dose of 4 mg/kg s.c. was selected. 2. Present studies were carried out to determine the time dependence of the effects produced by s.c. administration of a single dose of potassium cyanide as well as the recovery time of some of the toxicity indicative parameters. 3. It was found that cyanide effects continued for at least 3 days; after the parameters had recovered normal values.
Asunto(s)
Encéfalo/metabolismo , Hígado/metabolismo , Cianuro de Potasio/toxicidad , Tiosulfato Azufretransferasa/metabolismo , Animales , Relación Dosis-Respuesta a Droga , Complejo IV de Transporte de Electrones/antagonistas & inhibidores , Inyecciones Subcutáneas , Ratones , Miocardio/enzimología , Cianuro de Potasio/administración & dosificación , Cianuro de Potasio/sangre , Cianuro de Potasio/metabolismo , Tiosulfato Azufretransferasa/sangre , Factores de TiempoRESUMEN
1. Results of studies on the kinetics of hepatic rhodanese and the effects of S-adenosyl-L-methionine (SAM) on these kinetic parameters in cyanide-treated and non-treated mice are reported here. 2. The enzyme exhibited typical Michaelis-Menten behaviour with cyanide inhibition at concentrations higher than 50 mM. Km values of 4.74 and 0.85 mM were obtained for thiosulphate and cyanide, respectively, in control mice. 3. These results stress the biological importance of the rhodanese reaction for cyanide detoxification. 4. Km values were not significantly modified when the animals were intoxicated with a lethal (20 mg/kg) or a non-lethal (4 mg/kg) dose of cyanide. 5. SAM treatment either in control or in cyanide-poisoned animals doubled the Km's for cyanide.
Asunto(s)
Cianuros/envenenamiento , Hígado/enzimología , Sulfurtransferasas/metabolismo , Tiosulfato Azufretransferasa/metabolismo , Animales , Cinética , Hígado/efectos de los fármacos , Ratones , S-Adenosilmetionina/farmacología , Tiosulfatos/farmacologíaRESUMEN
1. The effect of colchicine, vincristine and griseofulvin (GRIS) on the porphyrinogenic action of 2-allyl-2-isopropylacetamide (AIA) and veronal was studied in vivo and using the in vitro experimental model of tissue explant cultures. 2. Complete prevention by colchicine was found in liver and heart explant from animals treated with AIA and veronal. 3. Vincristine, GRIS and colchicine reversed AIA induction in liver explants, however reversal was partial or nil in skin and heart explants depending on the antimitotic and the tissue. 4. The usefulness of the combination of the in vivo experimental model and the in vitro explant tissue culture model, for this kind of studies is emphasized.
Asunto(s)
Colchicina/farmacología , Hemo/metabolismo , Porfirinas/biosíntesis , 5-Aminolevulinato Sintetasa/antagonistas & inhibidores , 5-Aminolevulinato Sintetasa/biosíntesis , Alilisopropilacetamida/farmacología , Animales , Inducción Enzimática/efectos de los fármacos , Griseofulvina/farmacología , Técnicas In Vitro , L-Lactato Deshidrogenasa/metabolismo , Masculino , Ratones , Vincristina/farmacologíaRESUMEN
1. Present studies were carried out to establish the action of cyanide maintained at a high level during a period as long as desired. 2. One of the earliest effects of cyanide seems to be the inhibition of hepatic rhodanese. These changes do not seem to occur in the blood. 3. Available cyanide labile-sulfur was always altered, unless cyanide tissue levels could not be detected. 4. The inhibitory action of cyanide on enzymatic reaction involving Schiff base intermediates was also corroborated through its effect on delta-aminolevulinate acid dehydratase activity. 5. S-Adenosyl-L-methionine was not able to modify the toxic cyanide action.
Asunto(s)
Cianuro de Potasio/toxicidad , Animales , Encéfalo/metabolismo , Hígado/enzimología , Hígado/metabolismo , Ratones , Miocardio/metabolismo , Porfobilinógeno Sintasa/antagonistas & inhibidores , Cianuro de Potasio/administración & dosificación , Cianuro de Potasio/farmacocinética , S-Adenosilmetionina/farmacología , Bases de Schiff/metabolismo , Azufre/metabolismo , Tiosulfato Azufretransferasa/antagonistas & inhibidoresRESUMEN
The effects of oral chronic cyanide administration to mice were studied. Cyanide intoxication was confirmed by the increased levels of this poison and the concomitant inhibition of cytochrome oxidase activity in liver, brain, heart and blood. The detoxifying enzyme rhodanese was measured. The state of the sulfane sulfur pool was investigated by determination of the cyanide labile-sulfur levels. A clear correlation between rhodanese activity and sulfur content was obtained as a consequence of cyanide action. These results support the belief that rhodanese plays a fundamental role in the detoxification process of cyanide, in preventing cyanide reaching the target tissues.